{"id":41159,"date":"2024-05-16T10:57:25","date_gmt":"2024-05-16T10:57:25","guid":{"rendered":"https:\/\/conseil-concurrence.preprod.io\/communique-du-conseil-de-la-concurrence-relatif-au-projet-de-concentration-economique-concernant-la-prise-du-controle-exclusif-de-la-societe-valstar-s-a-par-la-societe-sun-pharmac-2\/"},"modified":"2026-02-06T12:42:11","modified_gmt":"2026-02-06T12:42:11","slug":"press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm","status":"publish","type":"post","link":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/","title":{"rendered":"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights"},"content":{"rendered":"<p>In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing information provided by the parties.<\/p>\n<p>This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council&#8217;s position on the proposed operation.<\/p>\n<p>The publication of this press release does not confirm the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law 104-12 on freedom of prices and competition as amended and supplemented.<\/p>\n<p><strong>Names of the companies involved:<\/strong><\/p>\n<ul>\n<li><strong>The acquirer<\/strong>: The company \u201cSun Pharmaceutical Industries Ltd\u201d;<\/li>\n<li><strong>The target<\/strong>: The company \u201cValstar S.A.\u201d.<\/li>\n<\/ul>\n<p><strong>Nature of the operation<\/strong><\/p>\n<ul>\n<li>Acquisition of exclusive control.<\/li>\n<\/ul>\n<p><strong>Economic sectors concerned by the operation<\/strong><\/p>\n<ul>\n<li>Manufacturing and distribution of pharmaceutical products.<\/li>\n<\/ul>\n<p><strong>Deadline for interested third parties to submit their observations<\/strong><\/p>\n<ul>\n<li>10 days from the date of publication of this press release, i.e. May 27, 2024.<\/li>\n<\/ul>\n<p><strong>NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES<\/strong><\/p>\n<p>The Competition Council has been notified of an economic concentration operation consisting of a project for the acquisition by the company \u201cSun Pharmaceutical Industries Ltd\u201d of the exclusive control of the company \u201cValstar S.A\u201d through the acquisition of 100% of its share capital and related voting rights.<\/p>\n<p>\u201cSun Pharmaceutical Industries Ltd\u201d is a limited liability company under Indian law, headquartered at SPARC Tandalja, Vadodara 390012, active in Morocco in the import, development, and manufacturing of pharmaceutical products through the company \u201cSun Pharmaceuticals Morocco LLC,\u201d a Moroccan company headquartered in Casablanca.<\/p>\n<p>\u201cValstar S.A.\u201d is a public limited company under Luxembourg law, active in Morocco in the import, development, and manufacturing of pharmaceutical products through the company \u201cKemipharm SA,\u201d a Moroccan company headquartered in Casablanca.<\/p>\n<p style=\"text-align: left;\">Done in Rabat on May 16, 2024<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council&#8217;s position on the proposed operation. The publication of this press release does not confirm the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law 104-12 on freedom of prices and competition as amended and supplemented. Names of the companies involved: The acquirer: The company \u201cSun Pharmaceutical Industries Ltd\u201d; The target: The company \u201cValstar S.A.\u201d. Nature of the operation Acquisition of exclusive control. Economic sectors concerned by the operation Manufacturing and distribution of pharmaceutical products. Deadline for interested third parties to submit their observations 10 days from the date of publication of this press release, i.e. May 27, 2024. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council has been notified of an economic concentration operation consisting of a project for the acquisition by the company \u201cSun Pharmaceutical Industries Ltd\u201d of the exclusive control of the company \u201cValstar S.A\u201d through the acquisition of 100% of its share capital and related voting rights. \u201cSun Pharmaceutical Industries Ltd\u201d is a limited liability company under Indian law, headquartered at SPARC Tandalja, Vadodara 390012, active in Morocco in the import, development, and manufacturing of pharmaceutical products through the company \u201cSun Pharmaceuticals Morocco LLC,\u201d a Moroccan company headquartered in Casablanca. \u201cValstar S.A.\u201d is a public limited company under Luxembourg law, active in Morocco in the import, development, and manufacturing of pharmaceutical products through the company \u201cKemipharm SA,\u201d a Moroccan company headquartered in Casablanca. Done in Rabat on May 16, 2024<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-41159","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights - Conseil de la concurrence du Maroc<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights - Conseil de la concurrence du Maroc\" \/>\n<meta property=\"og:description\" content=\"In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council&#8217;s position on the proposed operation. The publication of this press release does not confirm the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law 104-12 on freedom of prices and competition as amended and supplemented. Names of the companies involved: The acquirer: The company \u201cSun Pharmaceutical Industries Ltd\u201d; The target: The company \u201cValstar S.A.\u201d. Nature of the operation Acquisition of exclusive control. Economic sectors concerned by the operation Manufacturing and distribution of pharmaceutical products. Deadline for interested third parties to submit their observations 10 days from the date of publication of this press release, i.e. May 27, 2024. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council has been notified of an economic concentration operation consisting of a project for the acquisition by the company \u201cSun Pharmaceutical Industries Ltd\u201d of the exclusive control of the company \u201cValstar S.A\u201d through the acquisition of 100% of its share capital and related voting rights. \u201cSun Pharmaceutical Industries Ltd\u201d is a limited liability company under Indian law, headquartered at SPARC Tandalja, Vadodara 390012, active in Morocco in the import, development, and manufacturing of pharmaceutical products through the company \u201cSun Pharmaceuticals Morocco LLC,\u201d a Moroccan company headquartered in Casablanca. \u201cValstar S.A.\u201d is a public limited company under Luxembourg law, active in Morocco in the import, development, and manufacturing of pharmaceutical products through the company \u201cKemipharm SA,\u201d a Moroccan company headquartered in Casablanca. Done in Rabat on May 16, 2024\" \/>\n<meta property=\"og:url\" content=\"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/\" \/>\n<meta property=\"og:site_name\" content=\"Conseil de la concurrence du Maroc\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-16T10:57:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-06T12:42:11+00:00\" \/>\n<meta name=\"author\" content=\"Youssef OTMANE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Youssef OTMANE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\\\/\"},\"author\":{\"name\":\"Youssef OTMANE\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#\\\/schema\\\/person\\\/24b4bd1e24ccf3057c8fcb57662a0b81\"},\"headline\":\"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights\",\"datePublished\":\"2024-05-16T10:57:25+00:00\",\"dateModified\":\"2026-02-06T12:42:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\\\/\"},\"wordCount\":361,\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\\\/\",\"url\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\\\/\",\"name\":\"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights - Conseil de la concurrence du Maroc\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#website\"},\"datePublished\":\"2024-05-16T10:57:25+00:00\",\"dateModified\":\"2026-02-06T12:42:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#\\\/schema\\\/person\\\/24b4bd1e24ccf3057c8fcb57662a0b81\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/\",\"name\":\"Conseil de la concurrence du Maroc\",\"description\":\"Conseil de la concurrence\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#\\\/schema\\\/person\\\/24b4bd1e24ccf3057c8fcb57662a0b81\",\"name\":\"Youssef OTMANE\",\"url\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights - Conseil de la concurrence du Maroc","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/","og_locale":"en_US","og_type":"article","og_title":"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights - Conseil de la concurrence du Maroc","og_description":"In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council&#8217;s position on the proposed operation. The publication of this press release does not confirm the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law 104-12 on freedom of prices and competition as amended and supplemented. Names of the companies involved: The acquirer: The company \u201cSun Pharmaceutical Industries Ltd\u201d; The target: The company \u201cValstar S.A.\u201d. Nature of the operation Acquisition of exclusive control. Economic sectors concerned by the operation Manufacturing and distribution of pharmaceutical products. Deadline for interested third parties to submit their observations 10 days from the date of publication of this press release, i.e. May 27, 2024. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council has been notified of an economic concentration operation consisting of a project for the acquisition by the company \u201cSun Pharmaceutical Industries Ltd\u201d of the exclusive control of the company \u201cValstar S.A\u201d through the acquisition of 100% of its share capital and related voting rights. \u201cSun Pharmaceutical Industries Ltd\u201d is a limited liability company under Indian law, headquartered at SPARC Tandalja, Vadodara 390012, active in Morocco in the import, development, and manufacturing of pharmaceutical products through the company \u201cSun Pharmaceuticals Morocco LLC,\u201d a Moroccan company headquartered in Casablanca. \u201cValstar S.A.\u201d is a public limited company under Luxembourg law, active in Morocco in the import, development, and manufacturing of pharmaceutical products through the company \u201cKemipharm SA,\u201d a Moroccan company headquartered in Casablanca. Done in Rabat on May 16, 2024","og_url":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/","og_site_name":"Conseil de la concurrence du Maroc","article_published_time":"2024-05-16T10:57:25+00:00","article_modified_time":"2026-02-06T12:42:11+00:00","author":"Youssef OTMANE","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Youssef OTMANE","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/#article","isPartOf":{"@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/"},"author":{"name":"Youssef OTMANE","@id":"https:\/\/conseil-concurrence.ma\/en\/#\/schema\/person\/24b4bd1e24ccf3057c8fcb57662a0b81"},"headline":"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights","datePublished":"2024-05-16T10:57:25+00:00","dateModified":"2026-02-06T12:42:11+00:00","mainEntityOfPage":{"@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/"},"wordCount":361,"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/","url":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/","name":"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights - Conseil de la concurrence du Maroc","isPartOf":{"@id":"https:\/\/conseil-concurrence.ma\/en\/#website"},"datePublished":"2024-05-16T10:57:25+00:00","dateModified":"2026-02-06T12:42:11+00:00","author":{"@id":"https:\/\/conseil-concurrence.ma\/en\/#\/schema\/person\/24b4bd1e24ccf3057c8fcb57662a0b81"},"breadcrumb":{"@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-exclusive-takeover-of-the-company-valstar-s-a-by-the-company-sun-pharm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/conseil-concurrence.ma\/en\/"},{"@type":"ListItem","position":2,"name":"Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover of the company \u201cVALSTAR S.A\u201d by the company \u201cSUN PHARMACEUTICAL INDUSTRIES LTD\u201d through the acquisition of 100% of its share capital and related voting rights"}]},{"@type":"WebSite","@id":"https:\/\/conseil-concurrence.ma\/en\/#website","url":"https:\/\/conseil-concurrence.ma\/en\/","name":"Conseil de la concurrence du Maroc","description":"Conseil de la concurrence","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/conseil-concurrence.ma\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/conseil-concurrence.ma\/en\/#\/schema\/person\/24b4bd1e24ccf3057c8fcb57662a0b81","name":"Youssef OTMANE","url":"https:\/\/conseil-concurrence.ma\/en\/"}]}},"_links":{"self":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts\/41159","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/comments?post=41159"}],"version-history":[{"count":1,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts\/41159\/revisions"}],"predecessor-version":[{"id":45080,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts\/41159\/revisions\/45080"}],"wp:attachment":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/media?parent=41159"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/categories?post=41159"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/tags?post=41159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}